文传商讯
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in
2026-05-26 16:29:00
SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Speci
2026-05-26 16:29:00



